Compare DBD & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DBD | AORT |
|---|---|---|
| Founded | 1859 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.1B |
| IPO Year | N/A | 1993 |
| Metric | DBD | AORT |
|---|---|---|
| Price | $67.99 | $45.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $76.67 | $49.36 |
| AVG Volume (30 Days) | 232.0K | ★ 346.0K |
| Earning Date | 02-11-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43573.14 | N/A |
| EPS | ★ 1.35 | N/A |
| Revenue | ★ $3,690,400,000.00 | $422,646,000.00 |
| Revenue This Year | $2.72 | $15.97 |
| Revenue Next Year | $2.15 | $10.96 |
| P/E Ratio | $50.86 | ★ N/A |
| Revenue Growth | N/A | ★ 9.81 |
| 52 Week Low | $34.88 | $21.97 |
| 52 Week High | $69.94 | $48.25 |
| Indicator | DBD | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 59.32 | 48.90 |
| Support Level | $67.63 | $45.75 |
| Resistance Level | $69.94 | $48.00 |
| Average True Range (ATR) | 1.46 | 1.26 |
| MACD | -0.09 | -0.07 |
| Stochastic Oscillator | 51.42 | 33.59 |
Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are Banking, which offers integrated solutions for financial institutions, and Retail, which offers solutions, software, and services that improve the checkout process for retailers. A majority of its revenue is generated from the Banking segment. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA), followed by the Americas and the Asia-Pacific region.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.